SCHEMBL10590029

SCHEMBL10590029

CN(C)C(=O)CCSC(CCc1ccccc1C(=O)O)c1cccc(CCc2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9208043 0.92 — —
SCHEMBL9203516 0.89 — —
SCHEMBL9200778 0.88 — —
SCHEMBL9200788 0.88 — —
SCHEMBL9284533 0.85 — —
SCHEMBL9204399 0.84 ABCC1 (0.68) —
SCHEMBL9204404 0.84 ABCC1 (0.68) —
SCHEMBL9281256 0.84 — —
SCHEMBL9209227 0.84 — —
SCHEMBL10590033 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0318093-A2 Diarylquinoline diacids and their use as medicaments MERCK FROSST CANADA INC. (CA) 1989-05-31 — — EP claimed
Send feedback